Abstract:Objective: The aim of the current study was to investigate the effects of radioactive iodine-125 seed implantation on therapeutic efficacy, serum vascular endothelial growth factor (VEGF), carcinoembryonic antigen (CEA) levels, and prognosis of patients with ocular malignant tumors. Methods: A total of 86 patients with ocular malignant tumors were randomly allocated into the adjuvant chemotherapy group or iodine-125 seed implantation group, based on a random number table, with 43 patients in each group. The chemotherapy group underwent ocular tumor resections and routine postoperative adjuvant chemotherapy, while the iodine-125 group was treated with tumor resections and intraoperative iodine-125 seed implantation. At 3 months after surgery, after the chemotherapy group had received 2 cycles of chemotherapy, total effective rates were accessed in both groups. Serum CEA levels, before and after treatment, were detected by automatic electrochemiluminescence. Serum VEGF levels were also measured, before and after treatment, in both groups via ELISA. Correlation levels between CEA and VEGF were analyzed. Incidence rates of side effects, during treatment, were recorded and compared between the two groups. One-year progression-free survival and 3-year survival rates of the two groups were compared via regular follow-ups. Results: The total effective rate of the iodine-125 group was higher than that of chemotherapy group (P<0.05). In addition, expression levels of serum CEA and VEFG in the two groups, after treatment, were lower than those before treatment (all P<0.05). Decreases in the iodine-125 group were more significant than those in the chemotherapy group (both P<0.05). Serum CEA levels and VEGF levels were positively correlated. Incidence of side effects in the iodine-125 group was significantly lower than that in the chemotherapy group (P<0.05). Furthermore, 1-year progression-free survival and 3-year survival rates in the iodine-125 group were higher than those in the chemotherapy group. Differences were statistically significant (both P<0.05). Conclusion: Radioactive iodine-125 seed implantation in patients with ocular malignant tumors can effectively improve therapeutic efficacy, reduce serum levels of tumor markers CEA and VEGF, and improve 1-year progression-free survival and 3-year survival rates. This method shows a high level of safety. Thus, it is highly recommended for clinical practice.

The Efficacy and Safety of an Indocyanine Green-Macroaggregated Albumin-Hyaluronic Acid Mixture (LuminoMarkTM) for Surgical Localization of Recurrent Thyroid Cancer

Effects Of Radioactive Iodine-125 Seed Implantation On Therapeutic Efficacy, Serum Vegf, Cea Levels, And Prognosis Of Patients With Ocular Malignant Tumors

Dose Optimization of Intravenous Indocyanine Green for Malignant Lung Tumor Localization

Pre-incisional, trans-isthmic injection of indocyanine green for lymph node mapping during the transoral endoscopic thyroidectomy vestibular approach

Successful localisation of recurrent thyroid cancer using preoperative patent blue dye injection

Fluorescent and Iodized Emulsion for Preoperative Localization of Pulmonary Nodules

Comparative study on the diagnostic value of intravenous/ peritumoral injection of indocyanine green for metastatic lymph node location in patients with head and neck squamous cell carcinoma (HNSCC)

Preoperative tumor marking with indocyanine green (ICG) prior to minimally invasive colorectal cancer: a systematic review of current literature

Surgical outcomes of localization using indocyanine green fluorescence in breast conserving surgery: a prospective study

Clinical value of indocyanine green fluorescent labeling method in sentinel lymph node biopsy on patients with thyroid carcinoma

Indocyanine green fluorescence mapping of sentinel lymph node in patients with recurrent nasopharyngeal carcinoma after previous radiotherapy

Combined Indocyanine Green and Medical Glue Enables Stable and Precise Position in Animal Studies: Promising for Fluorescence-Guided Pulmonary Ground Glass Nodule Resection.

Sequential Diagnosis and Treatment for Colon Cancer via Derived Iridium and Indocyanine Green Hybrid Nanomicelles

Short-term and Long-Term Outcomes of Indocyanine Green for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer.

Indocyanine Green Can Stand Alone in Detecting Sentinel Lymph Nodes in Cervical Cancer

Autologous bone marrow infusion via portal vein combined with splenectomy for decompensated liver cirrhosis: A retrospective study

Feasibility and efficacy of indocyanine green in monitoring systemic drug leakage during isolated limb perfusion for recurrent melanoma of extremity

Intraoperative detection of sentinel lymph nodes in breast cancer patients using ultrasonography-guided direct indocyanine green dye-marking by real-time virtual sonography constructed with three-dimensional computed tomography-lymphography

MicBall800-coated Metal Clip as a Novel Fluorescent Marker for Image-guided Laparoscopic Surgery

Micro and Macroscopic Insights

Results of a Prospective Randomized Multicenter Study Comparing Indocyanine Green (ICG) Fluorescence Combined with a Standard Tracer Versus ICG Alone for Sentinel Lymph Node Biopsy in Early Breast Cancer: The INFLUENCE Trial